Filing Details
- Accession Number:
- 0000874015-13-000102
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-11 19:27:21
- Reporting Period:
- 2013-09-09
- Filing Date:
- 2013-09-11
- Accepted Time:
- 2013-09-11 19:27:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874015 | Isis Pharmaceuticals Inc | ISIS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 897667 | T Stanley Crooke | C/O Isis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Coo, President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-09-09 | 26,615 | $11.12 | 28,276 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-09-09 | 26,615 | $30.42 | 1,661 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-10 | 30,000 | $31.65 | 745,391 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2013-09-11 | 20,000 | $31.18 | 725,391 | No | 4 | S | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-09-09 | 26,615 | $0.00 | 26,615 | $11.12 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 58,740 | 2011-01-02 | 2014-01-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 174 | Indirect | By wife |
Footnotes
- Acquired as a result of exercising a stock option pursuant to a Rule 10b5-1 Trading Plan that was scheduled to expire on 1/1/14. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 6/27/2012.
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/27/2012.
Billionaire Hedge Funds
